Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management
International Journal of Radiation Oncology*Biology*Physics · 2024-10 · 120 (2) · e271
DOI: 10.1016/j.ijrobp.2024.07.604 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-10. Verfasst von J. Shephard und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shephard, J., Jagasia, S., Tasci, E., Joyce, T., Chappidi, S., Cooley-Zgela, T., Sproull, M., Mackey, M., Camphausen, K., & Krauze, A. (2024). Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management. International Journal of Radiation Oncology*Biology*Physics, 120(2), e271. https://doi.org/10.1016/j.ijrobp.2024.07.604
Vancouver
Shephard J, Jagasia S, Tasci E, Joyce T, Chappidi S, Cooley-Zgela T, et al. Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management. International Journal of Radiation Oncology*Biology*Physics. 2024;120(2):e271. doi:10.1016/j.ijrobp.2024.07.604
BibTeX
@article{Shephard2024,
author = {Shephard, J. and Jagasia, S. and Tasci, E. and Joyce, T. and Chappidi, S. and Cooley-Zgela, T. and Sproull, M. and Mackey, M. and Camphausen, K.A. and Krauze, A.V.},
title = {Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {120},
number = {2},
pages = {e271},
doi = {10.1016/j.ijrobp.2024.07.604}
}
EUVIMED